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ABSTRACT 
Introduction: One of the most frequently encountered intracranial tumours are the 
pituitary adenomas, these accounting for 5% to 20%. Therapeutic strategies vary 
largely, from medical therapy to complex neurosurgical procedures. The 
transsphenoidal approach can solve most of the lesions of the pituitary area, as long 
as the invasion of the adjacent structures is not significant. The transcranial approach 
is indicated in tumours with extensive invasion 
Materials and methods: We performed a retrospective study in the Bagdasar-Arseni 
Emergency Hospital Neurosurgery that aimed to analyze the demographics, signs 
and symptoms, therapeutic strategy, surgical approach, complications, and 
histopathology, from 2010 to 2019. 
Results: The total number of hospitalization records, including the follow-up 
hospitalization and/or second surgery hospitalization, was of 1107. Furthermore, 
there were 704 unique patients. The most common signs and symptoms 
encountered for the first admission were headache (245 – 34.56%), optic chiasm 
deficits (153 – 21.58%), acromegaly (85 – 11.99%). However, the majority of patients 
(507 – 71.51%) presented with some sort of hormonal imbalance or diabetes 
insipidus. On the one hand, a number of 325 (45.84%) patients had non-surgical 
treatment. On the other hand, a total of 384 (54.16%) surgeries for pituitary tumours 
were performed in this period. 
Discussion: In our study, the patients who underwent surgery benefited from either 
microsurgical transsphenoidal or transcranial surgeries. Even if the transsphenoidal 
approach was used far more, there was a greater relapse proportion in these 
patients. Transcranial surgery, even if followed by a far less proportion of relapse 
surgery, carried with it the burden of more days spent in hospital (most of the time 
twice as much as for the transsphenoidal patients). 
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Conclusion: Both transsphenoidal and transcranial 
approaches have advantages and disadvantages, thus the best 
strategy would be to tailor each surgery to each patient, 
keeping an open mind to all available approaches 
 
 
INTRODUCTION 
One of the most frequently encountered intracranial 
tumors are the pituitary adenomas, these 
accounting for 5% to 20% of all tumor lesions at this 
level. Most of the developing countries of the world 
estimate an incidence of about 20 cases per 100.000 
population (1), while European developed countries 
agree on 3,9-4 new cases per 100.000 people each 
year, the prevalence hovering between 78 and 94 
cases per 100.000 people.  
While most of the tumors that originate in the 
pituitary gland are usually benign, the behavior of 
these lesions can be unpredictable. Thus, one can 
encounter anything from clinically silent, indolent 
tumors, all the way to extremely aggressive 
malignancies. Therefore, a meticulous 
understanding of the anatomy of the area and also 
of the specific physiology of the hypothalamo-
pituitary complex is mandatory. (2) The therapeutic 
strategies vary largely, from medical therapy to 
complex neurosurgical procedures, depending on 
the aforementioned characteristics of the lesions.  
As far as signs and symptoms are concerned, 
these again vary according to the nature of the tumor 
and the local extension. The clinician has to look for 
hormonal dysfunction, visual field deficits, decreased 
visual acuity, anterior pituitary dysfunction and 
headache. (3) The usual therapeutic strategy is to try 
to medically manage any case. If this is not enough 
or neurological/hormonal deficits occur, the obvious 
step is taken towards surgical management. At this 
stage, the neurosurgeon has to decide which surgical 
approach and technique best tailors every case: 
transcranial, transsphenoidal microsurgical or 
transsphenoidal endoscopic, as well as any 
combined approach that he or she might find 
adequate.  
Regarding surgical approach used, one must look 
back to the era of Schloffer (1907), Hirsch (1910s) and 
Cushing (1920s). They were the ones who paved the 
road for the transsphenoidal approach for pituitary 
lesions. However, in the first half of the 20th century, 
due to lack of antibiotic therapy, the results were 
dismal. Hence, Cushing abandoned the technique 
and favored the transcranial approach. However, 
with introduction of the operating microscope, 
endoscope and development of powerful antibiotics, 
the transsphenoidal approach soon regained 
attention. Nowadays, there is a general consensus 
that the transsphenoidal approach can solve most of 
the lesions of the pituitary area, as long as the 
invasion of the adjacent structures is not significant. 
Furthermore, an experienced neurosurgeon, more 
familiar with the transcranial approach, will usually 
have similar results by using this method. Therefore, 
as long as the lesion permits both surgical strategies, 
it usually comes down to surgeon preferences and 
experience. Non the less, the more complex the 
lesion, the more surgeons prefer the transcranial 
approach. (3). 
 
MATERIALS AND METHODS 
This is a retrospective study conducted in the 
Bagdasar Arseni Emergency Hospital Neurosurgery 
Departments 3 and 4 that aims to analyze the 
demographics, signs and symptoms, therapeutic 
strategy, surgery approach used, complications 
associated with these approaches, histopathology of 
pituitary tumors, over the course of 10 years, from 
January 2010 to December 2019. 
To keep in line with confidentiality agreements 
and laws, each patient was coded and the original 
identification was removed. Data was collected 
directly from the electronic patient charts by the 
primary author.  
Data included in the study were age, gender, 
number of days of hospitalization, number of 
hospitalizations for each patient, signs, symptoms, 
type of surgery (approach used), perioperative 
complications (CSF leak, hematoma, neurological 
deficits) and also death within period of 
hospitalization. 
In order to be included in the study, the patients 
had to have diagnosis of pituitary tumor, be of either 
gender, with no limit in regard to age. The patient 
had to had been inbound in one of either 
Neurosurgery 3 or 4 Department and have an 
outgoing diagnosis of pituitary adenoma. All patients 
presenting with other sellar or parasellar masses 
were excluded (such as craniopharyngioma, 
epidermoid cyst, anterior circulation aneurysm). 
 
RESULTS 
The study included all patients presenting with 
pituitary tumors between January 2010 and 
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December 2019 on either of Department 3 or 4 of 
Neurosurgery in Bagdasar Arseni Hospital, 
Bucharest. Thus, 1107 hospitalization records were 
taken into account, including the follow-up 
hospitalization and/or second surgery 
hospitalization. Furthermore, there were 704 unique 
patients (personal identification numbers were 
analyzed). 
The gender distribution was 243 (34.27%) women 
and 466 (65.73%) men (figure 1), minimum age was 
14 and maximum was 84, with a mean age of 56.24 
(62.77 years old for women and 52.77 years old for 
men) (figure 2). 
 
 
 
Figure 1. 
 
 
 
Figure 2. 
 
The most common signs and symptoms 
encountered for the first admission were headache 
(245 – 34.56%), optic chiasm deficits (153 – 21.58%), 
acromegaly (85 – 11.99%). However, the majority of 
patients (507 – 71.51%) presented with some sort of 
hormonal imbalance or diabetes insipidus (figure 3). 
On the one hand, a number of 325 (45.84%) 
patients had non-surgical treatment: they were 
either referred to an Endocrinology Department to 
begin conservative treatment, or a "watchful waiting" 
ensued after the first radiological evaluation (figure 
4). 
 
 
Figure 3. 
 
 
 
Figure 4. 
 
On the other hand, a total of 384 (54.16%) surgeries 
for pituitary tumors were performed in this period as 
follows: 243 primary transsphenoidal surgeries, 36 
primary transcranial surgeries, 62 transsphenoidal 
reinterventions, 18 transcranial interventions for 
relapse after transsphenoidal surgeries, 6 
transsphenoidal surgeries after failed Gamma-Knife 
therapy, 8 combined approach surgeries (both 
transsphenoidal and transcranial) and 2 transcranial 
approaches after transcranial relapse (figure 5). 
 
 
 
Figure 5. 
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Out of the patients who underwent surgery, 122 
(31.77%) were macroadenomas, with extension 
ranging from only suprasellar, to one or both 
cavernous sinuses, anterior cranial fossa or third 
ventricle. 
The histopathology examination revealed 95 GH 
secreting tumors (24.74%), 21 ACTH secreting 
tumors (5.46%), 18 prolactinomas (4.68%), 11 
gonadotropin secreting hormones (2.86%). The rest 
were non secreting tumors (62.26%) (figure 6). 
 
 
 
Figure 6. 
 
The mean number of days of hospitalization was of 
7.5 for the entire group, with an average of 7 days for 
the transsphenoidal approach and an average of 13 
days for the transcranial approach (figure 7). 
 
 
 
Figure 7. 
 
The most common surgical complication 
encountered was pituitary insufficiency reported in 
23 cases, while CSF leakage was observed in 17 
cases. 
For the total number of hospitalizations, 4 deaths 
were recorded: one after transsphenoidal surgery of 
a patient with a macroadenoma invading both 
cavernous sinuses, two patients who presented with 
acute hydrocephalus at admission and GCS less than 
6, and one patient died of cardiac arrest in his sleep 
prior to surgery. No deaths were recorded for the 
transcranial group.  
 
DISCUSSIONS 
Hypothalamic/pituitary disorders represent a 
multifaceted pathology and, due to advancement of 
treatments, technology and understanding of 
physiopathology of the region, lately, not one type of 
strategy gets to be the gold standard. (2) Thus, recent 
understanding of complex mechanisms concerning 
cellular and molecular biology has brought medical 
treatment very high up in the list of strategies of 
treatment for pituitary tumors. Hence, almost half 
the patients who were admitted to our Neurosurgical 
Clinic benefited from a conservative treatment.  
On the other hand, even though there is no 
consensus on the world stage of neurosurgery 
regarding the gold standard treatment in case of 
incidental discovered pituitary tumors, there is a 
different story when it comes to tumors which 
provoke neurological deficits of any sort, endocrine 
dysfunction beyond the drugs' capacity of 
compensating, or even pose an immediate threat to 
the patient's life. Most recent articles (4), (5) suggest 
a surgical strategy as first option in these cases, but 
this is where the consensus stops. There are mainly 
three types of surgical approaches: transcranial, 
microsurgical transsphenoidal and endoscopic 
transsphenoidal, each with its own advantages and 
disadvantages. 
In our study, the patients who underwent surgery 
benefited from either microsurgical transsphenoidal 
or transcranial surgeries. Even if the transsphenoidal 
approach was used far more, there was a greater 
relapse proportion in these patients (figure 8). 
Furthermore, there were patients who underwent as 
many as 10 consecutive transsphenoidal surgeries in 
the course of the 10 years analyzed. Moreover, there 
were a number of patients who needed transcranial 
reintervention after the transsphenoidal approach 
did not offer the desired result. Only two patients 
underwent reintervention after transcranial 
approach, both of them with no relapse after the 
second surgery. 
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Figure 8. 
 
On the other hand, transcranial surgeries, even if 
followed by a far less proportion of relapse surgery, 
carried with it the burden of more days spent in 
hospital (most of the time twice as much as for the 
transsphenoidal patients). Moreover, there were 
cases in which the transcranial approach was not 
enough for the tumor to be completely removed, in 
which case, a second transsphenoidal approach was 
used during the same hospitalization (the combined 
approach cases – 8 patients). 
We also found a number of cases in which the 
first treatment option was Gamma-Knife therapy 
that proved not sufficient and a transsphenoidal 
approach was used in these cases. 
In accordance with most of the studies published, 
our patient data base revealed a clear dominance of 
male over female patients and also a younger age of 
debut for the disease (or diagnosis) for men as 
opposed to women. Furthermore, due to the relative 
early diagnosis in the natural evolution of the 
disease, only 122 cases out of 384 operated patients 
presented with macroadenommas. Moreover, all of 
the patients who underwent transcranial approach 
presented with macroadenomas. 
The most common symptoms that brought 
patients to the doctor were headache, optic chiasm 
deficits and body modification specific to GH 
hypersecretion. However, there was quite a large 
proportion of patients (mostly microadenomas) who 
were diagnosed with a brain tumor after the 
hormonal imbalances were discovered or patients 
who underwent a CT scan for another pathology (for 
example: post-traumatic CT scans performed after 
car crashes that reveal pituitary tumors). 
The most notable complications were CSF fistulae 
and pituitary insufficiency. These appeared in a total 
of less than 1% of all hospitalizations and less than 
7% out of the patients who underwent surgery (17 
fistulae, 23 pituitary insufficiency). Furthermore, all 
of the patients with CSF fistulae were part of the 
trassphenoidal approach group, none of the 
transcranial approach group presenting this 
complication. 
Out of the total number of hospitalizations (1107), 
4 deaths were reported, out of which only one 
directly related to the treatment option-
transsphenoidal surgery, thus a death rate of less 
than 0.72 for the entire group. 
 
CONCLUSIONS 
Even with the advancements in molecular and 
cellular biology, surgery remains one of the most 
important aspects of pituitary tumors treatment. 
Even if there is still no general consensus on what the 
ideal approach should be, our study reveals that 
both transsphenoidal and transcranial approaches 
have advantages and disadvantages, thus the best 
strategy would be to tailor each surgery to each 
patient, keeping an open mind to all available 
approaches.  
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